炎症性肠病合并非酒精性脂肪性肝病的研究进展Research Progress on Inflammatory Bowel Disease Complicated with Non-Alcoholic Fatty Liver Disease
马有泉, 荣光宏
临床医学进展Vol.13 No.6, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1361327, June 16 2023
炎症性肠病的活动性评估Active Assessment of Inflammatory Bowel Disease
肖金良, 胡瑞芳, 樊丽娟
临床医学进展Vol.12 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.12121588, December 7 2022
英夫利西单抗在炎症性肠病中的应用:现状与展望Application of Infliximab in Inflammatory Bowel Disease: Current Status and Prospects
李彦琴, 刘丹平
临床医学进展Vol.12 No.2, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.122139, February 16 2022
基于昼夜节律角度探讨肠道稳态对炎症性肠病的影响Effects of Intestinal Homeostasis on Inflammatory Bowel Disease Based on Circadian Rhythm
高新梅, 朱旭彤, 戴 帅, 周雪雷
临床医学进展Vol.13 No.10, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.13102223, October 13 2023
炎症性肠病的复发因素研究进展Research Progress of Relapse Factors in Inflammatory Bowel Disease
罗叶卿, 杨永林
临床医学进展Vol.12 No.7, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.127924, July 14 2022
英夫利西单抗联合硫唑嘌呤治疗炎症性肠病的临床研究进展Clinical Research Progress of Infliximab Combined with Azathioprine in the Treatment of Inflammatory Bowel Disease
胡瑞芳, 肖金良, 樊丽娟
临床医学进展Vol.12 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.12121582, December 6 2022